Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca²⁺ channels revealed by Timothy syndrome mutation

European Journal of Pharmacology
Xiaona ShengMitsuhiko Yamada

Abstract

Dihydropyridine Ca(2+) channel antagonists (DHPs) block Ca(V)1.2 L-type Ca(2+) channels (LTCCs) by stabilizing their voltage-dependent inactivation (VDI); however, it is still not clear how DHPs allosterically interact with the kinetically distinct (fast and slow) VDI. Thus, we analyzed the effect of a prototypical DHP, nifedipine on LTCCs with or without the Timothy syndrome mutation that resides in the I-II linker (L(I)-(II)) of Ca(V)1.2 subunits and impairs VDI. Whole-cell Ba(2+) currents mediated by rabbit Ca(V)1.2 with or without the Timothy mutation (G436R) (analogous to the human G406R mutation) were analyzed in the presence and absence of nifedipine. In the absence of nifedipine, the mutation significantly impaired fast closed- and open-state VDI (CSI and OSI) at -40 and 0 mV, respectively, but did not affect channels' kinetics at -100 mV. Nifedipine equipotently blocked these channels at -80 mV. In wild-type LTCCs, nifedipine promoted fast CSI and OSI at -40 and 0 mV and promoted or stabilized slow CSI at -40 and -100 mV, respectively. In LTCCs with the mutation, nifedipine resumed the impaired fast CSI and OSI at -40 and 0 mV, respectively, and had the same effect on slow CSI as in wild-type LTCCs. Therefore, nifedipi...Continue Reading

References

Jun 1, 1992·The Journal of General Physiology·R ShirokovE Ríos
Aug 1, 1991·The Journal of General Physiology·R W Hadley, W J Lederer
Jul 11, 1989·Nucleic Acids Research·M KammannB Gronenborn
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·B P Bean
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·G H HockermanW A Catterall
May 24, 2000·The Journal of Biological Chemistry·S C StotzG W Zamponi
Aug 7, 2001·British Journal of Pharmacology·S Berjukow, S Hering
Dec 26, 2001·The Journal of Biological Chemistry·Chengzhang Shi, Nikolai M Soldatov
Apr 23, 2003·Trends in Pharmacological Sciences·Nikolai M Soldatov
May 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Igor SplawskiMark T Keating
Oct 14, 2006·The Journal of Biological Chemistry·Alexandra RaybaudLucie Parent
Feb 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Curtis F Barrett, Richard W Tsien

❮ Previous
Next ❯

Citations

Aug 11, 2015·Protein Science : a Publication of the Protein Society·Xiaoguang LiuXu-Ri Huang
Jul 22, 2019·Experimental Biology and Medicine·Dan HanGuoliang Li
Jul 17, 2021·The Journal of General Physiology·Brooke M AhernJonathan Satin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.